China National Medicines Corp Ltd Financials

Market Capitalization CN¥24.05 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	11.11
Forward PE	10.15
Price to Sales TTM	CN¥0.47
Price to Book MRQ	CN¥1.45
Enterprise to Revenue	0.35
Enterprise to EBITDA	7.48

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	4.23%
Operating Margin	4.26%
Return on Assets TTM	4.36%
Return on Equity TTM	13.20%

Income Statement

Revenue TTM	CN¥51,194,916,864
Revenue per Share TTM	CN¥67.85
Quarterly Revenue Growth	7.10%
Gross Profit TTM	CN¥3,832,850,944
EBITDA	CN¥2,994,731,897
Net Income to Common TTM	CN¥2,164,974,592
Diluted EPS TTM	CN¥2.87
Quarterly Earnings Growth YoY	0.60%

Balance Sheet

Total Cash MRQ	CN¥8,298,101,760
Total Cash per Share MRQ	CN¥11.00
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	3.60
Current Ratio MRQ	2.04
Book Value per Share MRQ	CN¥22.01

Cash Flow

Operating Cash Flow TTM	CN¥1,687,590,656
Levered Free Cash Flow TTM	CN¥497,581,664

600511 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	754,502,976
Float Shares	324,111,853
Avg 10 Volume	3,434,217
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	57.05%
% Held by Institutions	12.19%

Stock Price Summary

Beta	0.50
Fifty Two Week Low	CN¥27.12
Fifty Two Week High	CN¥38.00
Fifty Two Week Change	2.82%
Day 50 MA	CN¥33.62
Day 200 MA	CN¥32.83

Dividends and Splits

Forward Annual Dividend Rate	CN¥3.42
Forward Annual Dividend Yield	10.72%
Trailing Annual Dividend Rate	CN¥0.85
Trailing Annual Dividend Yield	2.68%
Payout Ratio	29.76%
Dividend Date
Ex Dividend Date	2024-06-13
Last Split Factor
Last Split Date	2009-06-03